Di-p-toluoyl-L-tartaric acid monohydrate Cas:32634-66-5

We are Di-p-toluoyl-L-tartaric acid monohydrate CAS:32634-66-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Di-p-toluoyl-L-tartaric acid monohydrate

Synonyms:
(-)-O,O’-Di-p-toluoyl-L-tartaric Acid
(2R,3R)-2,3-Bis((4-methylbenzoyl)oxy)succinic acid
L-PTTA
LDTTA
o,o-ToluoyllTartaricAcid
di-p-toluoyl-D-tartaric acid
(-)-di-O,O'-P-toluyl-L-tartaric acid
Di-p-Toluoy-L-Tartaric Acid
Tartaric acid,di-p-toluate
(-)-di-O,O-p-toluoyl tartaric acid
Di-4-Toluoyl-L-tartaric acid
Di-P-Toluoyl-L-Tartaric Acid
(-)-Di-p-toluoyl-L-tartaric Acid
(-)-Di-1,4-O-Toluoyl-L-Tart
(2R,3R)-(-)-di-O-(p-toluoyl)-tartaric acid
(-)-Di-p-toluoyl-L-t
(+ )-Di-1,4-toluoyl-Ltartaricacid
DTTA
di-O,O'-p-toluyl-D-tartaric acid
(-)-O,O`-Di-p-toluoyl-L-tartaric Acid
 
molecular formula: C20H20O9
Molecular weight: 404.36700
 
Physical Properties:
Appearance and properties: off-white crystalline powder
Density: 1.371 g/cm3
Boiling point: 626.5ºC at 760 mmHg
Melting point: 164-170ºC
Flash point: 223.2ºC

 
Specification:
Analysis Contents Specification Result
 
Appearance
White or off-white powder or crystilline powder White crystilline powder
Assay ≥99.0% 99.95%
Specific rotation[ α]D20
(c=1, ethanol)
 
-136o~ -143o
-139.7o
Melting point 99-101oC Conform
Clarity Clear clear
Melting point 169~ 171oC 169.5~170.6oC
Water Di-p-toluoyl-L-tartaric acid monohydrate Cas:32634-66-5 第2张 0.5% 0.06%
Conclusion The product meets the factory standard
 
Application:
Widely used for chiral resolution of amine compounds
 
Package and Storage:
1kg/bottle or bag
25kgs/drum or bag
 
 



Market News:MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world. 2-isopropyl-2,4,4-trimethyl-6,7-diaza-bicyclo[3.2.2]non-6-en-3-one manufacturer.“The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added. 5,5-dibenzyl-5H-benzo[4,5]imidazo[2,1-a]isoquinolin-6-one supplier.“This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. Benzene, 1,1′-[[1-(methoxymethyl)-1,2-ethanediyl]bis(seleno)]bis- producer.

Related Products
Product Name
Tris(trimethylsilyl) borate Cas:4325-85-3 View Details
2-(2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl)ethanamine View Details
2-Butyl Octanedioic acid View Details
(1-Aminoethyl)phosphinic acid manufacturer Butyl 2-chloroacetate manufacturer 1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride manufacturer 4-Amino-2-chloropyridine manufacturer Pentapeptide-3 manufacturer